Effect of fluocinolone acetonide 0.2 µg/day implant on the decision to drive in patients with diabetic macular oedema: a report from the FAME study.
Effect of fluocinolone acetonide 0.2 µg/day implant on the decision to drive in patients with diabetic macular oedema: a report from the FAME study. BMJ Open Ophthalmol. 2019; 4(1):e000405.